West Pharmaceutical: A High-Quality Beat-And-Raise With More Upside Ahead [Seeking Alpha]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Seeking Alpha
WST's growth is driven by robust demand for High-Value Product components, biologics, and a favorable mix shift, supporting margin expansion and durable earnings momentum. Management raised FY26 guidance to $3.35B revenue and $8.75 adjusted EPS, reflecting operational strength but maintaining a conservative outlook amid macro uncertainties. I maintain a buy rating on WST, citing premium valuation justified by double-digit organic growth, strategic capital allocation, and structural advantages in drug delivery systems. andresr/E+ via Getty Images Thesis I thought West Pharmaceutical Services, Inc. ( WST ) delivered a pretty clear beat-and-raise quarter . We have a 1Q26 adjusted EPS of $2.13 coming in about $0.45 ahead of expectations, and revenue reaching $844.9 million, a figure that also Margin expansion is fueled by a mix shift toward higher-margin High-Value Product components, strong biologics demand, and operational efficiencies, with adjusted operating margin up 350
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- West Pharmaceutical Services (WST) was given a new $315.00 price target by Morgan Stanley.MarketBeat
- West Pharmaceutical Services (WST) was given a new $310.00 price target by Barclays PLC.MarketBeat
- West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]Yahoo! Finance
- 3 Inflated Stocks with Open Questions [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services (WST) had its "buy" rating reaffirmed by Citigroup Inc..MarketBeat
WST
Earnings
- 4/23/26 - Beat
WST
Sec Filings
- 4/23/26 - Form 10-Q
- 4/23/26 - Form 8-K
- 4/1/26 - Form 4
- WST's page on the SEC website